RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
23andMe Holding Co. - Stock

23andMe Holding Co. Revenue 2024

23andMe Holding Co. Revenue

219.64 M USD

Ticker

ME

ISIN

US90138Q1085

In 2024, 23andMe Holding Co.'s sales reached 219.64 M USD, a -26.67% difference from the 299.5 M USD sales recorded in the previous year.

The 23andMe Holding Co. Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2029e524.0618,96
2028e526.8518,86
2027e312.3431,82
2026e284.4234,94
2025e243.240,86
2024219.6445,25
2023299.544,91
2022271.948,88
2021243.947,97
2020305.544,98
2019440.943,75
2018440.943,75

23andMe Holding Co. Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into 23andMe Holding Co., a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by 23andMe Holding Co. from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects 23andMe Holding Co.’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of 23andMe Holding Co.. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into 23andMe Holding Co.’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing 23andMe Holding Co.’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on 23andMe Holding Co.’s growth potential.

23andMe Holding Co. Revenue, Profit, and EBIT History

Date23andMe Holding Co. Revenue23andMe Holding Co. EBIT23andMe Holding Co. Net Income
2029e524.06 M undefined0 undefined0 undefined
2028e526.85 M undefined0 undefined0 undefined
2027e312.34 M undefined-249.85 M undefined-246.17 M undefined
2026e284.42 M undefined-332.35 M undefined-282.78 M undefined
2025e243.2 M undefined-368.88 M undefined-307.78 M undefined
2024219.64 M undefined-318.98 M undefined-666.7 M undefined
2023299.5 M undefined-324 M undefined-311.7 M undefined
2022271.9 M undefined-254.2 M undefined-217.5 M undefined
2021243.9 M undefined-185.2 M undefined-183.6 M undefined
2020305.5 M undefined-213.7 M undefined-250.9 M undefined
2019440.9 M undefined-188.8 M undefined-183.5 M undefined
2018440.9 M undefined-188.8 M undefined-183.5 M undefined

23andMe Holding Co. stock margins

The 23andMe Holding Co. margin analysis displays the gross margin, EBIT margin, as well as the profit margin of 23andMe Holding Co.. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for 23andMe Holding Co..

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the 23andMe Holding Co.'s sales revenue. A higher gross margin percentage indicates that the 23andMe Holding Co. retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the 23andMe Holding Co.'s earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the 23andMe Holding Co.'s total revenue generated. When comparing the revenue margin year over year, investors can gauge the 23andMe Holding Co.'s growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the 23andMe Holding Co.. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the 23andMe Holding Co.'s financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

23andMe Holding Co. Margin History

23andMe Holding Co. Gross margin23andMe Holding Co. Profit margin23andMe Holding Co. EBIT margin23andMe Holding Co. Profit margin
2029e45.25 %0 %0 %
2028e45.25 %0 %0 %
2027e45.25 %-79.99 %-78.82 %
2026e45.25 %-116.85 %-99.42 %
2025e45.25 %-151.68 %-126.55 %
202445.25 %-145.23 %-303.55 %
202344.91 %-108.18 %-104.07 %
202248.88 %-93.49 %-79.99 %
202147.97 %-75.93 %-75.28 %
202044.98 %-69.95 %-82.13 %
201943.75 %-42.82 %-41.62 %
201843.75 %-42.82 %-41.62 %

23andMe Holding Co. Aktienanalyse

What does 23andMe Holding Co. do?

23andMe Holding Co. is an American company for personalized genomics and health research. The company was founded in 2006 and is headquartered in Sunnyvale, California. The name of the company comes from the 23 chromosomes in the human genome and the English expression for "me". The main business of 23andMe is DNA analysis for consumers. Customers can send their DNA samples to the company, with tests being conducted on more than 30 genetic traits, uncovering disease risks, and creating family trees. 23andMe uses advanced sequencing technologies to analyze more than one million genetic variations in your genome. The DNA samples are tested based on single nucleotide polymorphisms (SNPs), which can provide information about disease risks, ethnic origins, and family health history. The results are then provided on an online platform where customers can view and share their DNA information. One unique aspect of 23andMe is that it also collects genetic information for research. 23andMe collaborates with various universities and research institutions to gather data for more complex studies. Customers can participate by anonymously sharing their genetic data for research purposes. 23andMe has many advantages, such as the ability to predict the risk of certain diseases. Based on your DNA, 23andMe can determine if there are altered genes in your body that are associated with specific diseases. However, the company emphasizes that this is not a diagnosis and should not replace medical advice. 23andMe also emphasizes that it supports customers in conversations with their doctors and gives them the opportunity to discuss the results with their doctors and relatives. In addition to DNA analysis, the company also offers a genetic report on your fitness traits. 23andMe also provides details on how to better understand your genetic information and what you can do to improve your health. In 2013, 23andMe underwent a regulatory investigation, which led to a significant restriction of its services. The company had to discontinue its health risk assessments for customers due to concerns from the FDA. The FDA was concerned that customers might make medical decisions based on 23andMe reports that may not necessarily be good for them. However, after many discussions with the FDA, the company decided to relaunch and is now an even more well-known and successful company. The company has more than 10 million customers worldwide and is continuously growing. An emotional incentive for consumers to use 23andMe is the desire to know where they come from and who their ancestors were. Nearly 50 percent of 23andMe customers have chosen to release their DNA information for research purposes. 23andMe has already contributed to various research initiatives that have made important contributions to genomics and precision medicine. Overall, 23andMe offers a unique experience for customers as it presents genomics and personal health data in an accessible way. It is also a significant contribution to research in the field. The company has achieved a lot despite regulatory challenges along the way. 23andMe Holding Co. ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding 23andMe Holding Co.'s Sales Figures

The sales figures of 23andMe Holding Co. originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing 23andMe Holding Co.’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize 23andMe Holding Co.'s sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in 23andMe Holding Co.’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about 23andMe Holding Co. Stock

How much revenue did 23andMe Holding Co. generate this year?

23andMe Holding Co. has achieved a revenue of 219.64 M USD this year.

How much was the turnover of the company 23andMe Holding Co. compared to the previous year?

The revenue of 23andMe Holding Co. has increased by -26.67% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of 23andMe Holding Co.?

The revenue of 23andMe Holding Co. is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of 23andMe Holding Co. measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of 23andMe Holding Co. so important for investors?

The revenue of 23andMe Holding Co. is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does 23andMe Holding Co. pay?

Over the past 12 months, 23andMe Holding Co. paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, 23andMe Holding Co. is expected to pay a dividend of 0 USD.

What is the dividend yield of 23andMe Holding Co.?

The current dividend yield of 23andMe Holding Co. is .

When does 23andMe Holding Co. pay dividends?

23andMe Holding Co. pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of 23andMe Holding Co.?

23andMe Holding Co. paid dividends every year for the past 0 years.

What is the dividend of 23andMe Holding Co.?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is 23andMe Holding Co. located?

23andMe Holding Co. is assigned to the 'Health' sector.

Wann musste ich die Aktien von 23andMe Holding Co. kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of 23andMe Holding Co. from 6/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/20/2024.

When did 23andMe Holding Co. pay the last dividend?

The last dividend was paid out on 6/20/2024.

What was the dividend of 23andMe Holding Co. in the year 2023?

In the year 2023, 23andMe Holding Co. distributed 0 USD as dividends.

In which currency does 23andMe Holding Co. pay out the dividend?

The dividends of 23andMe Holding Co. are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von 23andMe Holding Co.

Our stock analysis for 23andMe Holding Co. Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 23andMe Holding Co. Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.